Arafarma Group, S.A. Report issue

For profit Phase 3 Phase 4
Founded: Guadalajara Spain (2003)

Organization Overview

First Clinical Trial
2010
NCT05029297
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Arafarma Group, S.A.

Active Ingredients

Drugs in Phase 4 Trials (2)

d-mannose (1 trial)

oligomeric proanthocyanidins (1 trial)

Drugs in Phase 3 Trials (1)

capsaicin (qutenza) (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3